Industry Focus

Marijuana stock CannTrust has revealed its been growing pot in unlicensed rooms, calling into question its future as a cannabis leader. Also, here’s why Gilead Sciences’ CEO just inked a multibillion deal with Galapagos to develop drugs together.

Direct download: IF_07242019_final.mp3
Category:Podcast -- posted at: 4:47pm EST

1